CorVel Announces Record Earnings(000 14961000 Net income ...),Health
000 14,961,000
Net income 18,576,000 23,384,000
Earnings Per Share:
Basic $1.32 $1.69
Diluted $1.30 $1.67
Weighted Shares
Basic 14,070,000 13,856,000
Diluted 14,268,000 14,036,000
CorVel Corporation
Quarterly Results - Condensed Balance Sheet
March 31, 2007 and March 31, 2008
March 31, 2007 March 31, 2008
Cash 15,020,000 17,911,000
Accounts receivable, net 41,027,000 39,164,000
Prepaid expenses and taxes 3,090,000 5,242,000
Deferred income taxes 5,150,000 6,753,000
Property, net 24,864,000 30,569,000
Goodwill and other assets 24,617,000 39,708,000
Total 113,768,000 139,347,000
Accounts and taxes payable 13,418,000 20,476,000
Accrued liabilities 15,851,000 16,473,000
Deferred tax liability 5,302,000 6,020,000
Paid in capital 75,557,000 80,222,000
Treasury stock -154,091,000 -162,302,000
Retained earnings 157,731,000 178,458,000
Total 113,768,000 139,347,000
'/>"/>
| SOURCE CorVel Corporation Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. CorVel Announces Appearance at Bank of America Health Care Conference
2. CorVel to Present at UBS Global Healthcare Services Conference
3. CorVel Announces Record Earnings Per Share
4. CorVel Corporation Announces Resumption of Stock Repurchases
5. SUA Insurance Company Announces Partnership With American Safety Indemnity Company
6. WellPoint Announces Appearance at Upcoming Conference
7. MINRAD International, Inc. Announces FDA Approval of Petrem(TM) Sevoflurane
8. Synthetech Announces Appointment of Dr. Gregory R. Hahn as President and Chief Executive Officer
9. Mylan Announces Final FDA Approval for Zaleplon Capsules
10. PharMEDium Announces National Rollout of Electronic 222 Ordering Initiative
11. Senetek PLC Announces Key Personnel Appointments
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |